Global Overactive Bladder Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 10-Sep-2018
No. of pages: 128

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

Scope of the Report:

This report focuses on the Overactive Bladder Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.

Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.

The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.

The worldwide market for Overactive Bladder Treatment is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 6460 million US$ in 2023, from 4710 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Astellas Pharma

- Allergan

- Pfizer

- Teva (Activas)

- Johnson & Johnson

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Anticholinergics

- Mirabegron

- Botox

Market Segment by Applications, can be divided into

- Idiopathic Overactive Bladder

- Neurogenic Overactive Bladder

There are 15 Chapters to deeply display the global Overactive Bladder Treatment market.

Chapter 1, to describe Overactive Bladder Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Overactive Bladder Treatment, with sales, revenue, and price of Overactive Bladder Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Overactive Bladder Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Overactive Bladder Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Overactive Bladder Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Overactive Bladder Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Overactive Bladder Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Anticholinergics
1.2.2 Mirabegron
1.2.3 Botox
1.3 Market Analysis by Applications
1.3.1 Idiopathic Overactive Bladder
1.3.2 Neurogenic Overactive Bladder
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Business Overview
2.1.2 Overactive Bladder Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Overactive Bladder Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Overactive Bladder Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva (Activas)
2.4.1 Business Overview
2.4.2 Overactive Bladder Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Overactive Bladder Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Overactive Bladder Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Overactive Bladder Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Overactive Bladder Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Overactive Bladder Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Overactive Bladder Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Overactive Bladder Treatment Market Analysis by Regions
4.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Overactive Bladder Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Overactive Bladder Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
4.5 South America Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
5 North America Overactive Bladder Treatment by Countries
5.1 North America Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Overactive Bladder Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Overactive Bladder Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
6 Europe Overactive Bladder Treatment by Countries
6.1 Europe Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Overactive Bladder Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Overactive Bladder Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
6.3 UK Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
6.4 France Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Overactive Bladder Treatment by Countries
7.1 Asia-Pacific Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Overactive Bladder Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Overactive Bladder Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
7.5 India Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
8 South America Overactive Bladder Treatment by Countries
8.1 South America Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Overactive Bladder Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Overactive Bladder Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Overactive Bladder Treatment by Countries
9.1 Middle East and Africa Overactive Bladder Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Overactive Bladder Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Overactive Bladder Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
10 Global Overactive Bladder Treatment Market Segment by Type
10.1 Global Overactive Bladder Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Overactive Bladder Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2013-2018)
10.2 Anticholinergics Sales Growth and Price
10.2.1 Global Anticholinergics Sales Growth (2013-2018)
10.2.2 Global Anticholinergics Price (2013-2018)
10.3 Mirabegron Sales Growth and Price
10.3.1 Global Mirabegron Sales Growth (2013-2018)
10.3.2 Global Mirabegron Price (2013-2018)
10.4 Botox Sales Growth and Price
10.4.1 Global Botox Sales Growth (2013-2018)
10.4.2 Global Botox Price (2013-2018)
11 Global Overactive Bladder Treatment Market Segment by Application
11.1 Global Overactive Bladder Treatment Sales Market Share by Application (2013-2018)
11.2 Idiopathic Overactive Bladder Sales Growth (2013-2018)
11.3 Neurogenic Overactive Bladder Sales Growth (2013-2018)
12 Overactive Bladder Treatment Market Forecast (2018-2023)
12.1 Global Overactive Bladder Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Overactive Bladder Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Overactive Bladder Treatment Market Forecast (2018-2023)
12.2.2 Europe Overactive Bladder Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Overactive Bladder Treatment Market Forecast (2018-2023)
12.2.4 South America Overactive Bladder Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Overactive Bladder Treatment Market Forecast (2018-2023)
12.3 Overactive Bladder Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Overactive Bladder Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Overactive Bladder Treatment Market Share Forecast by Type (2018-2023)
12.4 Overactive Bladder Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Overactive Bladder Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Overactive Bladder Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Overactive Bladder Treatment Picture
Table Product Specifications of Overactive Bladder Treatment
Figure Global Sales Market Share of Overactive Bladder Treatment by Types in 2017
Table Overactive Bladder Treatment Types for Major Manufacturers
Figure Anticholinergics Picture
Figure Mirabegron Picture
Figure Botox Picture
Figure Overactive Bladder Treatment Sales Market Share by Applications in 2017
Figure Idiopathic Overactive Bladder Picture
Figure Neurogenic Overactive Bladder Picture
Figure United States Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Overactive Bladder Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Overactive Bladder Treatment Type and Applications
Table Astellas Pharma Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Overactive Bladder Treatment Type and Applications
Table Allergan Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Overactive Bladder Treatment Type and Applications
Table Pfizer Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva (Activas) Basic Information, Manufacturing Base and Competitors
Table Teva (Activas) Overactive Bladder Treatment Type and Applications
Table Teva (Activas) Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Overactive Bladder Treatment Type and Applications
Table Johnson & Johnson Overactive Bladder Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Overactive Bladder Treatment Sales by Manufacturer (2016-2017)
Figure Global Overactive Bladder Treatment Sales Market Share by Manufacturer in 2016
Figure Global Overactive Bladder Treatment Sales Market Share by Manufacturer in 2017
Table Global Overactive Bladder Treatment Revenue by Manufacturer (2016-2017)
Figure Global Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2016
Figure Global Overactive Bladder Treatment Revenue Market Share by Manufacturer in 2017
Figure Top 3 Overactive Bladder Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Overactive Bladder Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Global Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table Global Overactive Bladder Treatment Sales by Regions (2013-2018)
Table Global Overactive Bladder Treatment Sales Market Share by Regions (2013-2018)
Table Global Overactive Bladder Treatment Revenue by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Revenue Market Share by Regions in 2013
Figure Global Overactive Bladder Treatment Revenue Market Share by Regions in 2017
Figure North America Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Europe Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure South America Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure North America Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table North America Overactive Bladder Treatment Sales by Countries (2013-2018)
Table North America Overactive Bladder Treatment Sales Market Share by Countries (2013-2018)
Figure North America Overactive Bladder Treatment Sales Market Share by Countries in 2013
Figure North America Overactive Bladder Treatment Sales Market Share by Countries in 2017
Table North America Overactive Bladder Treatment Revenue by Countries (2013-2018)
Table North America Overactive Bladder Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Overactive Bladder Treatment Revenue Market Share by Countries in 2013
Figure North America Overactive Bladder Treatment Revenue Market Share by Countries in 2017
Figure United States Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Canada Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Mexico Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Europe Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table Europe Overactive Bladder Treatment Sales by Countries (2013-2018)
Table Europe Overactive Bladder Treatment Sales Market Share by Countries (2013-2018)
Table Europe Overactive Bladder Treatment Revenue by Countries (2013-2018)
Figure Europe Overactive Bladder Treatment Revenue Market Share by Countries in 2016
Figure Europe Overactive Bladder Treatment Revenue Market Share by Countries in 2017
Figure Germany Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure UK Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure France Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Russia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Italy Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Overactive Bladder Treatment Sales by Countries (2013-2018)
Table Asia-Pacific Overactive Bladder Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Overactive Bladder Treatment Sales Market Share by Countries 2017
Table Asia-Pacific Overactive Bladder Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific Overactive Bladder Treatment Revenue Market Share by Countries 2017
Figure China Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Japan Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Korea Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure India Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure South America Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table South America Overactive Bladder Treatment Sales by Countries (2013-2018)
Table South America Overactive Bladder Treatment Sales Market Share by Countries (2013-2018)
Figure South America Overactive Bladder Treatment Sales Market Share by Countries in 2017
Table South America Overactive Bladder Treatment Revenue by Countries (2013-2018)
Table South America Overactive Bladder Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Overactive Bladder Treatment Revenue Market Share by Countries in 2017
Figure Brazil Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Argentina Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Colombia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Overactive Bladder Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Overactive Bladder Treatment Sales by Countries (2013-2018)
Table Middle East and Africa Overactive Bladder Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Overactive Bladder Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa Overactive Bladder Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure UAE Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Egypt Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure Nigeria Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Figure South Africa Overactive Bladder Treatment Sales and Growth Rate (2013-2018)
Table Global Overactive Bladder Treatment Sales by Type (2013-2018)
Table Global Overactive Bladder Treatment Sales Share by Type (2013-2018)
Table Global Overactive Bladder Treatment Revenue by Type (2013-2018)
Table Global Overactive Bladder Treatment Revenue Share by Type (2013-2018)
Figure Global Anticholinergics Sales Growth (2013-2018)
Figure Global Anticholinergics Price (2013-2018)
Figure Global Mirabegron Sales Growth (2013-2018)
Figure Global Mirabegron Price (2013-2018)
Figure Global Botox Sales Growth (2013-2018)
Figure Global Botox Price (2013-2018)
Table Global Overactive Bladder Treatment Sales by Application (2013-2018)
Table Global Overactive Bladder Treatment Sales Share by Application (2013-2018)
Figure Global Neurogenic Overactive Bladder Sales Growth (2013-2018)
Figure Global Overactive Bladder Treatment Sales, Revenue and Growth Rate (2018-2023)
Table Global Overactive Bladder Treatment Sales Forecast by Regions (2018-2023)
Table Global Overactive Bladder Treatment Market Share Forecast by Regions (2018-2023)
Figure North America Sales Overactive Bladder Treatment Market Forecast (2018-2023)
Figure Europe Sales Overactive Bladder Treatment Market Forecast (2018-2023)
Figure Asia-Pacific Sales Overactive Bladder Treatment Market Forecast (2018-2023)
Figure South America Sales Overactive Bladder Treatment Market Forecast (2018-2023)
Figure Middle East and Africa Sales Overactive Bladder Treatment Market Forecast (2018-2023)
Table Global Overactive Bladder Treatment Sales Forecast by Type (2018-2023)
Table Global Overactive Bladder Treatment Market Share Forecast by Type (2018-2023)
Table Global Overactive Bladder Treatment Sales Forecast by Application (2018-2023)
Table Global Overactive Bladder Treatment Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global and Chinese Overactive Bladder Treatment Industry, 2018 Market Research Report
    Published: 13-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Overactive Bladder Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Overactive Bladder Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Overactive Bladder Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overv......
  • Alpha-Mannosidosis Global Clinical Trials Review, H2, 2018
    Published: 31-Oct-2018        Price: US 2500 Onwards        Pages: 45
    Alpha-Mannosidosis Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Alpha-Mannosidosis Global Clinical Trials Review, H2, 2018" provides an overview of Alpha-Mannosidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha-Mannosidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of di......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2018
    Published: 25-Oct-2018        Price: US 2500 Onwards        Pages: 276
    Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2018" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of tria......
  • Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Global Clinical Trials Review, H2, 2018
    Published: 25-Oct-2018        Price: US 2500 Onwards        Pages: 73
    Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Global Clinical Trials Review, H2, 2018" provides an overview of Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenoleukodyst......
  • Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2018
    Published: 25-Oct-2018        Price: US 2500 Onwards        Pages: 74
    Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2018" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across......
  • Kidney Fibrosis - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 156
    Kidney Fibrosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis - Pipeline Review, H2 2018, provides an overview of the Kidney Fibrosis (Genito Urinary System And Sex Hormones) pipeline landscape. Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis......
  • Overactive Bladder - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 109
    Overactive Bladder - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H2 2018, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape. Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may ......
  • Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 222
    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito Urinary System And Sex Hormones) pipeline landscape. Chronic kidney disease is the slow loss of kidney function over time. Signs an......
  • Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2018-2025
    Published: 01-Oct-2018        Price: US 3900 Onwards        Pages: 90
    Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2017, North America accounts for 49.59%. Followed North America, Europe is the second largest consumption mark......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs